Zhejiang East-Asia Pharmaceutical Co Ltd Class A 605177
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 22.05
- Day Range
- CNY 21.70–23.08
- 52-Week Range
- CNY 14.96–34.89
- Bid/Ask
- CNY 22.97 / CNY 23.01
- Market Cap
- CNY 2.64 Bil
- Volume/Avg
- 1.8 Mil / 1.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 27.06
- Price/Sales
- 2.14
- Dividend Yield (Trailing)
- 1.26%
- Dividend Yield (Forward)
- 1.26%
- Total Yield
- 1.26%
Company Profile
Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,435
- Website
- http://www.eapharm.cn
Comparables
Valuation
|
Metric
|
605177
|
600285
|
600216
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.06 | 24.16 | 46.21 |
Price/Book Value | 1.30 | 4.85 | 0.95 |
Price/Sales | 2.14 | 4.14 | 1.16 |
Price/Cash Flow | — | 18.28 | 14.60 |
Price/Earnings
605177
600285
600216
Financial Strength
|
Metric
|
605177
|
600285
|
600216
|
|---|---|---|---|
Quick Ratio | 1.49 | 1.14 | 1.54 |
Current Ratio | 2.49 | 1.49 | 2.38 |
Interest Coverage | 34.61 | — | 13.45 |
Quick Ratio
605177
600285
600216
Profitability
|
Metric
|
605177
|
600285
|
600216
|
|---|---|---|---|
Return on Assets (Normalized) | 3.47% | 12.44% | 1.27% |
Return on Equity (Normalized) | 5.40% | 21.12% | 1.68% |
Return on Invested Capital (Normalized) | 3.92% | 19.26% | 1.59% |
Return on Assets
605177
600285
600216
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| Ctdtxpcx | Kqjqwl | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Crjfsccf | Hjnkmv | $114.2 Bil | |||
| Moderna Inc
MRNA
| Lqjhnzts | Fzjhl | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Wswldqhb | Fhqwk | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Kwcwvtkg | Pjpfm | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Xvtqqqwg | Wybhnyk | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Sqtkwwbt | Ytxjsl | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Znsczfqyr | Vgdn | $12.8 Bil | |||
| Incyte Corp
INCY
| Xvfxlgd | Yhncp | $12.2 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Pvbrnqlrl | Bhvdnw | $12.2 Bil |